MAKO Surgical Conference Scuttlebutt

MAKO Surgical (Nasdaq: MAKO  ) made an appearance at the Piper Jaffray investor conference this week, partially in order to address some investor concerns about why the company needed to raise capital now, and why it decided to tap the equity markets versus using its available credit line with Deerfield Capital Management. In this video, Motley Fool health care analyst Brenton Flynn discusses what MAKO said about those points, and he highlights a few other interesting tidbits from the conference presentation and question-and-answer sessions.

For investors looking to learn more about MAKO Surgical and exactly what makes this stock a buy or a sell, Fool.com analyst and MAKO expert David Meier has authored a premium research report covering all of the must-know details on the company, including key areas to watch and risks looming in the future. As an added bonus, David will keep you informed with a full year of updates and guidance on MAKO Surgical as news breaks. Click here now to learn more and start reading.


Read/Post Comments (0) | Recommend This Article (4)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2131049, ~/Articles/ArticleHandler.aspx, 9/2/2014 5:56:16 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement